Literature DB >> 33750330

Severe extensive community acquired aspergillus infection in a full-term infant accompanied with increases in white blood cell counts and C-reactive protein: a case report.

Yanli Wang1, Wenjing Chen1, Wenshen Wu2, Dongling Yu1, Huiheng Yan1, Xiuzhen Ye3.   

Abstract

BACKGROUND: Aspergillus infection is more common among premature infants in neonatal intensive care units, who have decreased qualitative immune defenses and need various invasive treatment procedures. It is rare in normal full-term neonates, especially in newborn babies from the community. Moreover, the white blood cell (WBC) count and C-reactive protein (CRP) level may be normal or slightly changed in fungal infections, but the neonate reported in this study had significant increases in WBC and CRP. To the best of our knowledge, this is the first report on a full-term neonate from the community with aspergillus infection accompanied by significant increases in WBC and CRP levels. CASE
PRESENTATION: A 28-day-old infant, who received empirical antibiotic treatment for 10 days because of neonatal pneumonia, was referred to our neonatal department from the local hospital. The infant had persistent infection and multiple organ failure syndromes. Bronchoscopy and deep sputum smear were performed to identify the pathogen, which confirmed aspergillus infection in the sputum. Fluconazole was immediately administered, but the baby died after three days. Thereafter, an autopsy was performed with parental consent. There were multiple necrotic areas in the lungs and liver, and pathological examination revealed aspergillus.
CONCLUSIONS: The present case emphasized that community-sourced aspergillus infection can exist in full-term neonates, with significantly increased WBC count and CRP level. Advanced antibiotics were not effective in this case, and fungal infections should have been considered earlier.

Entities:  

Keywords:  Aspergilloma; Aspergillus infection; Community infection; Full‐term neonate; Significant increases in WBC and CRP

Year:  2021        PMID: 33750330      PMCID: PMC7941996          DOI: 10.1186/s12887-021-02588-1

Source DB:  PubMed          Journal:  BMC Pediatr        ISSN: 1471-2431            Impact factor:   2.125


  10 in total

1.  Early proinflammatory cytokines and C‐reactive protein trends as predictors of outcome in invasive Aspergillosis.

Authors:  Louis A Chai; Mihai G Netea; Steven Teerenstra; Arul Earnest; Alieke G Vonk; Haran T Schlamm; Raoul Herbrecht; Peter F Troke; Bart Jan Kullberg
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

Review 2.  Invasive mould infections in newborns and children.

Authors:  Elio Castagnola; Maura Faraci; Francesca Fioredda; Loredana Amoroso; Francesco Risso; Alessia Franceschi; Roberto Bandettini; Gian Michele Magnano; Alessio Pini Prato; Chiara Gardella; Serena Arrigo; Marco Gattorno; Giorgio Piaggio; Antonella Ciucci; Ines Lorenzi; Anna Loy; Riccardo Haupt
Journal:  Early Hum Dev       Date:  2011-02-01       Impact factor: 2.079

Review 3.  Negative (1,3)-β-D-glucan and Elevated White Blood Cells Combined Procalcitonin Masquerading as Severe Pneumonia Eventually Diagnosed as Invasive Pulmonary Aspergillosis Proven by Bronchoalveolar Lavage Fluid Culture in a Diabetes Patient: a Case Report and Literature Review.

Authors:  Yan L Ge; Qian Zhang; Meng H Wang; Li Q Li; Ai S Fu; Cong H Liu; Hai F Zhang; Wen Q Li; Yi Chen; Shuang Zhang; Chen Hao; Ci Zhang; Xiao Y Zhu
Journal:  Clin Lab       Date:  2019-08-01       Impact factor: 1.138

Review 4.  Epidemiology of invasive fungal infections in neonates and children.

Authors:  W J Steinbach
Journal:  Clin Microbiol Infect       Date:  2010-09       Impact factor: 8.067

5.  Neonatal Candidiasis: New Insights into an Old Problem at a Unique Host-Pathogen Interface.

Authors:  Amanda B Arsenault; Joseph M Bliss
Journal:  Curr Fungal Infect Rep       Date:  2015-09-07

6.  Evolution of procalcitonin, C-reactive protein and fibrinogen levels in neutropenic leukaemia patients with invasive pulmonary aspergillosis or mucormycosis.

Authors:  Marjorie Roques; Marie Lorraine Chretien; Camille Favennec; Ingrid Lafon; Emmanuelle Ferrant; Caroline Legouge; Alexia Plocque; Camille Golfier; Laurence Duvillard; Lucie Amoureux; Jean Noel Bastie; Lory Maurin-Bernier; Frederic Dalle; Denis Caillot
Journal:  Mycoses       Date:  2016-03-02       Impact factor: 4.377

7.  Serum procalcitonin rise is only slight in two cases of disseminated aspergillosis.

Authors:  G Beaune; F Bienvenu; C Pondarré; G Monneret; J Bienvenu; G Souillet
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

8.  A Prospective, International Cohort Study of Invasive Mold Infections in Children.

Authors:  Rachel L Wattier; Christopher C Dvorak; Jill A Hoffman; Ava A Brozovich; Ibrahim Bin-Hussain; Andreas H Groll; Elio Castagnola; Katherine M Knapp; Theoklis E Zaoutis; Britt Gustafsson; Lillian Sung; David Berman; Natasha B Halasa; Mark J Abzug; Aristea Velegraki; Tanvi S Sharma; Brian T Fisher; William J Steinbach
Journal:  J Pediatric Infect Dis Soc       Date:  2014-07-16       Impact factor: 3.164

9.  Management of Invasive Fungal Disease in Neonates and Children.

Authors:  Laura Ferreras-Antolín; Mike Sharland; Adilia Warris
Journal:  Pediatr Infect Dis J       Date:  2019-06       Impact factor: 2.129

Review 10.  Simultaneous primary invasive cutaneous aspergillosis in two preterm twins: case report and review of the literature.

Authors:  Floriane Gallais; Julie Denis; Olfa Koobar; Laurence Dillenseger; Dominique Astruc; Raoul Herbrecht; Ermanno Candolfi; Valérie Letscher-Bru; Marcela Sabou
Journal:  BMC Infect Dis       Date:  2017-08-02       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.